Treatment of cutaneous leishmaniasis with nitric-oxide donor

Lancet. 1998 Apr 18;351(9110):1176-7. doi: 10.1016/s0140-6736(05)79119-4.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Topical
  • Adolescent
  • Adult
  • Animals
  • Child
  • Child, Preschool
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Humans
  • Leishmania braziliensis / drug effects*
  • Leishmaniasis, Cutaneous / drug therapy*
  • Leishmaniasis, Cutaneous / physiopathology
  • Male
  • Nitric Oxide / physiology
  • Penicillamine / administration & dosage
  • Penicillamine / analogs & derivatives*
  • Treatment Outcome

Substances

  • S-nitro-N-acetylpenicillamine
  • Nitric Oxide
  • Penicillamine